$CAH
CARDINAL HEALTH INC

2020 Q2 Form 10-Q Financial Statement

#000072137120000043 Filed on May 11, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2020 Q1 2019 Q1
Revenue $36.69B $39.16B $35.23B
YoY Change -1.78% 11.15% 4.74%
Cost Of Revenue $35.10B $37.27B $33.46B
YoY Change -1.63% 11.38% 5.5%
Gross Profit $1.590B $1.885B $1.764B
YoY Change -5.02% 6.86% -7.79%
Gross Profit Margin 4.33% 4.81% 5.01%
Selling, General & Admin $1.137B $1.165B $1.097B
YoY Change -2.65% 6.2% -3.09%
% of Gross Profit 71.51% 61.8% 62.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $225.0M $224.0M $261.0M
YoY Change -6.64% -14.18% 0.77%
% of Gross Profit 14.15% 11.88% 14.8%
Operating Expenses $1.137B $1.165B $1.097B
YoY Change -2.65% 6.2% -3.09%
Operating Profit $453.0M $562.0M $432.0M
YoY Change -10.47% 30.09% -20.88%
Interest Expense $530.0M $60.00M $75.00M
YoY Change -891.04% -20.0% -10.71%
% of Operating Profit 117.0% 10.68% 17.36%
Other Income/Expense, Net $22.00M -$19.00M $13.00M
YoY Change -1200.0% -246.15% 550.0%
Pretax Income $815.0M $478.0M $370.0M
YoY Change 241.0% 29.19% -20.26%
Income Tax $158.0M -$127.0M $74.00M
% Of Pretax Income 19.39% -26.57% 20.0%
Net Earnings $656.0M $350.0M $296.0M
YoY Change 238.14% 18.24% 16.08%
Net Earnings / Revenue 1.79% 0.89% 0.84%
Basic Earnings Per Share
Diluted Earnings Per Share $2.239M $1.190M $990.0K
COMMON SHARES
Basic Shares Outstanding 292.0M shares 292.0M shares 298.0M shares
Diluted Shares Outstanding 294.0M shares 299.0M shares

Balance Sheet

Concept 2020 Q2 2020 Q1 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.771B $2.329B $3.438B
YoY Change 9.48% -32.26% 58.07%
Cash & Equivalents $2.771B $2.329B $3.438B
Short-Term Investments
Other Short-Term Assets $1.707B $1.692B $1.643B
YoY Change -12.28% 2.98% -3.64%
Inventory $13.20B $12.81B $12.62B
Prepaid Expenses
Receivables $8.264B $9.019B $7.879B
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $25.94B $25.85B $25.58B
YoY Change 0.75% 1.04% 8.8%
LONG-TERM ASSETS
Property, Plant & Equipment $2.366B $2.299B $2.322B
YoY Change 0.42% -0.99% -7.89%
Goodwill $8.357B $8.339B $8.330B
YoY Change -0.25% 0.11% -17.51%
Intangibles $2.918B $3.039B $3.530B
YoY Change -14.93% -13.91% -15.97%
Long-Term Investments
YoY Change
Other Assets $1.185B $1.623B $1.045B
YoY Change 12.64% 55.31% 49.71%
Total Long-Term Assets $14.83B $15.30B $15.23B
YoY Change -2.56% 0.48% -13.08%
TOTAL ASSETS
Total Short-Term Assets $25.94B $25.85B $25.58B
Total Long-Term Assets $14.83B $15.30B $15.23B
Total Assets $40.77B $41.15B $40.81B
YoY Change -0.48% 0.83% -0.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.37B $22.00B $20.52B
YoY Change -0.75% 7.23% 9.48%
Accrued Expenses $2.231B $2.179B $1.951B
YoY Change 5.14% 11.69% -8.62%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $10.00M $508.0M $1.451B
YoY Change -97.79% -64.99% 163.34%
Total Short-Term Liabilities $23.62B $24.67B $23.92B
YoY Change -2.05% 3.14% 11.63%
LONG-TERM LIABILITIES
Long-Term Debt $6.765B $6.754B $7.629B
YoY Change -10.74% -11.47% -15.49%
Other Long-Term Liabilities $341.0M $381.0M
YoY Change
Total Long-Term Liabilities $7.106B $7.135B $7.629B
YoY Change -6.24% -6.48% -15.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.62B $24.67B $23.92B
Total Long-Term Liabilities $7.106B $7.135B $7.629B
Total Liabilities $38.98B $39.95B $34.58B
YoY Change 12.54% 15.52% 3.24%
SHAREHOLDERS EQUITY
Retained Earnings $1.170B $656.0M $5.386B
YoY Change -78.47% -87.82% -9.6%
Common Stock $2.789B $2.774B $2.748B
YoY Change 0.94% 0.95% 1.4%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.066B $2.086B $1.793B
YoY Change 15.42% 16.34% 59.24%
Treasury Stock Shares 34.00M shares 35.00M shares 29.00M shares
Shareholders Equity $1.789B $1.203B $6.230B
YoY Change
Total Liabilities & Shareholders Equity $40.77B $41.15B $40.81B
YoY Change -0.48% 0.83% -0.54%

Cashflow Statement

Concept 2020 Q2 2020 Q1 2019 Q1
OPERATING ACTIVITIES
Net Income $656.0M $350.0M $296.0M
YoY Change 238.14% 18.24% 16.08%
Depreciation, Depletion And Amortization $225.0M $224.0M $261.0M
YoY Change -6.64% -14.18% 0.77%
Cash From Operating Activities $240.0M $1.676B $1.480B
YoY Change -52.57% 13.24% 91.71%
INVESTING ACTIVITIES
Capital Expenditures -$136.0M -$90.00M -$76.00M
YoY Change 0.0% 18.42% -2.56%
Acquisitions
YoY Change
Other Investing Activities $878.0M -$8.000M -$8.000M
YoY Change -2472.97% 0.0% -100.93%
Cash From Investing Activities $742.0M -$98.00M -$84.00M
YoY Change -528.9% 16.67% -110.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -528.0M -912.0M -142.0M
YoY Change -57.52% 542.25% -77.71%
NET CHANGE
Cash From Operating Activities 240.0M 1.676B 1.480B
Cash From Investing Activities 742.0M -98.00M -84.00M
Cash From Financing Activities -528.0M -912.0M -142.0M
Net Change In Cash 454.0M 666.0M 1.254B
YoY Change -149.89% -46.89% 36.9%
FREE CASH FLOW
Cash From Operating Activities $240.0M $1.676B $1.480B
Capital Expenditures -$136.0M -$90.00M -$76.00M
Free Cash Flow $376.0M $1.766B $1.556B
YoY Change -41.43% 13.5% 83.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Entity Central Index Key
EntityCentralIndexKey
0000721371
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000000 shares
CY2019Q1 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2020Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
755000000 shares
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
CY2020Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
327000000 shares
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2019Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2020Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2019Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2019Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
28000000 shares
CY2020Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
35000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-03-31
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-11373
dei Entity Registrant Name
EntityRegistrantName
Cardinal Health, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-0958666
dei Entity Address Address Line1
EntityAddressAddressLine1
7000 Cardinal Place
dei Entity Address City Or Town
EntityAddressCityOrTown
Dublin
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43017
dei City Area Code
CityAreaCode
(614)
dei Local Phone Number
LocalPhoneNumber
757-5000
dei Security12b Title
Security12bTitle
Common shares (without par value)
dei Trading Symbol
TradingSymbol
CAH
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Shell Company
EntityShellCompany
false
us-gaap Interest Expense
InterestExpense
227000000 USD
CY2020Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
291986422 shares
CY2020Q1 us-gaap Revenues
Revenues
39157000000 USD
CY2019Q1 us-gaap Revenues
Revenues
35228000000 USD
us-gaap Revenues
Revenues
116233000000 USD
us-gaap Revenues
Revenues
108181000000 USD
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
37272000000 USD
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
33464000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
110955000000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
103021000000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
1885000000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
1764000000 USD
us-gaap Gross Profit
GrossProfit
5278000000 USD
us-gaap Gross Profit
GrossProfit
5160000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1165000000 USD
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1097000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3435000000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3315000000 USD
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
-6000000 USD
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
53000000 USD
us-gaap Restructuring Charges
RestructuringCharges
80000000 USD
us-gaap Restructuring Charges
RestructuringCharges
97000000 USD
CY2020Q1 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
130000000 USD
CY2019Q1 cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
154000000 USD
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
395000000 USD
cah Amortizationandotheracquisitionrelatedcosts
Amortizationandotheracquisitionrelatedcosts
468000000 USD
CY2020Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
1000000 USD
CY2019Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-11000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-7000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
492000000 USD
CY2020Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-35000000 USD
CY2019Q1 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-17000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-5729000000 USD
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-20000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
562000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
432000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4368000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1752000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-19000000 USD
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-21000000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-13000000 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
60000000 USD
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
370000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9000000 USD
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5000000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4587000000 USD
CY2019Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1512000000 USD
CY2019Q1 us-gaap Interest Expense
InterestExpense
75000000 USD
us-gaap Interest Expense
InterestExpense
189000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
478000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
127000000 USD
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
74000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-237000000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
342000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
351000000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
296000000 USD
us-gaap Profit Loss
ProfitLoss
-4350000000 USD
us-gaap Profit Loss
ProfitLoss
1170000000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
350000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
296000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4352000000 USD
us-gaap Net Income Loss
NetIncomeLoss
1169000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.20
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.99
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-14.84
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
3.89
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.19
CY2019Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.99
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-14.84
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
3.88
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
292000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
298000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
294000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
293000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
302000000 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4811
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.4763
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.4433
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.4289
CY2020Q1 us-gaap Profit Loss
ProfitLoss
351000000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
296000000 USD
us-gaap Profit Loss
ProfitLoss
-4350000000 USD
us-gaap Profit Loss
ProfitLoss
1170000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
13000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-35000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
12000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-62000000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-16000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-19000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
313000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-21000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-1000000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-27000000 USD
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
-3000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
308000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4412000000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1151000000 USD
CY2020Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2019Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2000000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
312000000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
308000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4414000000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1150000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2329000000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2531000000 USD
CY2020Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
9019000000 USD
CY2019Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
8448000000 USD
CY2020Q1 us-gaap Inventory Net
InventoryNet
12808000000 USD
CY2019Q2 us-gaap Inventory Net
InventoryNet
12822000000 USD
CY2020Q1 us-gaap Other Assets Current
OtherAssetsCurrent
1692000000 USD
CY2019Q2 us-gaap Other Assets Current
OtherAssetsCurrent
1946000000 USD
CY2020Q1 us-gaap Assets Current
AssetsCurrent
25848000000 USD
CY2019Q2 us-gaap Assets Current
AssetsCurrent
25747000000 USD
CY2020Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2299000000 USD
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2356000000 USD
CY2020Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11378000000 USD
CY2019Q2 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
11808000000 USD
CY2020Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1623000000 USD
CY2019Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1052000000 USD
CY2020Q1 us-gaap Assets
Assets
41148000000 USD
CY2019Q2 us-gaap Assets
Assets
40963000000 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
21984000000 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21535000000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
508000000 USD
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
452000000 USD
CY2019Q2 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
2945000000 USD
CY2020Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2179000000 USD
CY2019Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2122000000 USD
CY2020Q1 us-gaap Liabilities Current
LiabilitiesCurrent
24671000000 USD
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
24109000000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6754000000 USD
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7579000000 USD
CY2020Q1 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
8517000000 USD
CY2019Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q1 us-gaap Common Stock Value
CommonStockValue
2774000000 USD
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
2763000000 USD
CY2020Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
656000000 USD
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5434000000 USD
CY2020Q1 us-gaap Treasury Stock Value
TreasuryStockValue
2086000000 USD
CY2019Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1790000000 USD
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-141000000 USD
CY2019Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-79000000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1203000000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
6328000000 USD
CY2020Q1 us-gaap Minority Interest
MinorityInterest
3000000 USD
CY2019Q2 us-gaap Minority Interest
MinorityInterest
2000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1206000000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6330000000 USD
CY2020Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41148000000 USD
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40963000000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1002000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
350000000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
351000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-38000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-38000000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
35000000 USD
CY2020Q1 us-gaap Dividends
Dividends
142000000 USD
CY2020Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-2000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1206000000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6043000000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
296000000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
296000000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
12000000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
22000000 USD
CY2019Q1 us-gaap Dividends
Dividends
143000000 USD
CY2019Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6232000000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6330000000 USD
us-gaap Net Income Loss
NetIncomeLoss
-4352000000 USD
us-gaap Profit Loss
ProfitLoss
-4350000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-62000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
65000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
350000000 USD
us-gaap Dividends
Dividends
426000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1206000000 USD
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6059000000 USD
us-gaap Net Income Loss
NetIncomeLoss
1169000000 USD
us-gaap Profit Loss
ProfitLoss
1170000000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-19000000 USD
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
49000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
600000000 USD
us-gaap Dividends
Dividends
429000000 USD
us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6232000000 USD
us-gaap Profit Loss
ProfitLoss
-4350000000 USD
us-gaap Profit Loss
ProfitLoss
1170000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
688000000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
759000000 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
0 USD
us-gaap Loss On Sale Of Investments
LossOnSaleOfInvestments
2000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-7000000 USD
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
492000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
68000000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
64000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
86000000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
653000000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
156000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8000000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
345000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
448000000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
846000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-5425000000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-309000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1720000000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2216000000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
38000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
239000000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
192000000 USD
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
18000000 USD
cah Purchaseofavailableforsalesecuritiesandotherinvestments
Purchaseofavailableforsalesecuritiesandotherinvestments
11000000 USD
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
6000000 USD
cah Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
Proceedsfromsaleofavailableforsalesecuritiesandotherinvestments
3000000 USD
cah Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
2000000 USD
cah Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
Proceedsfromdivestituresanddisposalofpropertyandequipmentandheldforsaleassets
749000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-249000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
511000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-2000000 USD
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
888000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000 USD
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-4000000 USD
cah Netproceedstaxwithholdingsfromsharebasedcompensation
Netproceedstaxwithholdingsfromsharebasedcompensation
-13000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
428000000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
435000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
350000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
600000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1672000000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1050000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1000000 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-2000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-202000000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
1675000000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2531000000 USD
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1763000000 USD
CY2020Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2329000000 USD
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3438000000 USD
CY2019Q3 cah Lease Liabilitiesestablishedasa Resultoftheadoptionof Asc842
LeaseLiabilitiesestablishedasaResultoftheadoptionofASC842
422000000 USD
CY2020Q1 us-gaap Severance Costs1
SeveranceCosts1
-15000000 USD
CY2019Q1 us-gaap Severance Costs1
SeveranceCosts1
29000000 USD
CY2020Q1 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
9000000 USD
CY2019Q1 cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
24000000 USD
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
-6000000 USD
CY2019Q1 us-gaap Restructuring Charges
RestructuringCharges
53000000 USD
us-gaap Severance Costs1
SeveranceCosts1
47000000 USD
us-gaap Severance Costs1
SeveranceCosts1
70000000 USD
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
33000000 USD
cah Facility Exit And Other Costs
FacilityExitAndOtherCosts
27000000 USD
us-gaap Restructuring Charges
RestructuringCharges
80000000 USD
us-gaap Restructuring Charges
RestructuringCharges
97000000 USD
CY2019Q2 us-gaap Restructuring Reserve
RestructuringReserve
72000000 USD
us-gaap Restructuring Costs
RestructuringCosts
67000000 USD
us-gaap Payments For Restructuring
PaymentsForRestructuring
58000000 USD
CY2020Q1 us-gaap Restructuring Reserve
RestructuringReserve
81000000 USD
CY2019Q2 us-gaap Goodwill
Goodwill
8378000000 USD
us-gaap Goodwill Transfers
GoodwillTransfers
-5000000 USD
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-34000000 USD
CY2020Q1 us-gaap Goodwill
Goodwill
8339000000 USD
CY2020Q1 us-gaap Reporting Unit Percentage Of Fair Value In Excess Of Carrying Amount
ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount
0.10
cah Discount Ratefairvalueinputs
DiscountRatefairvalueinputs
0.085
cah Terminal Growth Ratefairvalueinputs
TerminalGrowthRatefairvalueinputs
0.02
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22000000 USD
CY2020Q1 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5822000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2805000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3017000000 USD
us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P12Y
CY2020Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5844000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2805000000 USD
CY2020Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3039000000 USD
CY2019Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22000000 USD
CY2019Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
22000000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5836000000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2428000000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3408000000 USD
CY2019Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
5858000000 USD
CY2019Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2428000000 USD
CY2019Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
3430000000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
129000000 USD
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
133000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
385000000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
399000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
134000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
442000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
408000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
358000000 USD
CY2020Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
328000000 USD
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
31000000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
92000000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1000000 USD
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
9000000 USD
CY2020Q1 cah Total Finance Lease Cost
TotalFinanceLeaseCost
1000000 USD
cah Total Finance Lease Cost
TotalFinanceLeaseCost
9000000 USD
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
5000000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
17000000 USD
CY2020Q1 us-gaap Lease Cost
LeaseCost
37000000 USD
us-gaap Lease Cost
LeaseCost
118000000 USD
CY2020Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
469000000 USD
CY2020Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
109000000 USD
CY2020Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
381000000 USD
CY2020Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
490000000 USD
CY2020Q1 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
13000000 USD
CY2020Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4000000 USD
CY2020Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10000000 USD
CY2020Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
14000000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
95000000 USD
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
4000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
154000000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
17000000 USD
CY2019Q3 cah Reclassificationofdeferredrentinaccordancewith Asc842
ReclassificationofdeferredrentinaccordancewithASC842
22000000 USD
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y6M
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.028
CY2020Q1 cah Lessee Lease Liability Payments Remainder Of Fiscal Year
LesseeLeaseLiabilityPaymentsRemainderOfFiscalYear
30000000 USD
CY2020Q1 cah Lessee Lease Liability Payments Due Year Two
LesseeLeaseLiabilityPaymentsDueYearTwo
119000000 USD
CY2020Q1 cah Lessee Lease Liability Payments Due Year Three
LesseeLeaseLiabilityPaymentsDueYearThree
99000000 USD
CY2020Q1 cah Lessee Lease Liability Payments Due Year Four
LesseeLeaseLiabilityPaymentsDueYearFour
77000000 USD
CY2020Q1 cah Lessee Lease Liability Payments Due Year Five
LesseeLeaseLiabilityPaymentsDueYearFive
55000000 USD
CY2020Q1 cah Lessee Lease Liability Payments Due After Year Five
LesseeLeaseLiabilityPaymentsDueAfterYearFive
173000000 USD
CY2020Q1 cah Total Lease Liability Payments Due
TotalLeaseLiabilityPaymentsDue
553000000 USD
CY2020Q1 cah Total Lease Liability Not Yet Commenced Amount
TotalLeaseLiabilityNotYetCommencedAmount
4000000 USD
CY2020Q1 cah Total Lease Liability Undiscounted Excess Amount
TotalLeaseLiabilityUndiscountedExcessAmount
45000000 USD
CY2020Q1 cah Total Lease Liability
TotalLeaseLiability
504000000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
126000000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
100000000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
76000000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
54000000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
33000000 USD
CY2019Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
94000000 USD
CY2020Q1 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
7300000000 USD
CY2019Q2 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
8000000000.0 USD
CY2020Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
22000000000.0 USD
CY2019Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
21500000000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-9000000 USD
CY2020Q1 us-gaap Other Borrowings
OtherBorrowings
14000000 USD
CY2019Q2 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
8031000000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
508000000 USD
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
452000000 USD
CY2020Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
6754000000 USD
CY2019Q2 us-gaap Other Borrowings
OtherBorrowings
10000000 USD
CY2020Q1 cah Total Long Termand Short Term Obligations
TotalLongTermandShortTermObligations
7262000000 USD
CY2019Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7579000000 USD
CY2020Q1 cah Opioid Total Settlement Cuyahogaand Summit Counties
OpioidTotalSettlementCuyahogaandSummitCounties
215000000 USD
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.268
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.200
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.052
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.226
CY2020Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
919000000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
456000000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
772000000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
303000000 USD
CY2020Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
137000000 USD
CY2019Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
122000000 USD
CY2020Q1 us-gaap Change In Unrealized Gain Loss On Fair Value Hedging Instruments1
ChangeInUnrealizedGainLossOnFairValueHedgingInstruments1
0 USD
CY2020Q1 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
7262000000 USD
CY2019Q2 cah Carrying Amountof Long Termandother Short Term Borrowings
CarryingAmountofLongTermandotherShortTermBorrowings
8031000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
350000000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
600000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
292000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
298000000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
294000000 shares
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
299000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
293000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
293000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
302000000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000000 shares
cah Sharesthatwouldbeantidilutiveasaresultofnetloss
Sharesthatwouldbeantidilutiveasaresultofnetloss
2000000 shares
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000000 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2 segment
CY2020Q1 us-gaap Revenues
Revenues
39157000000 USD
CY2019Q1 us-gaap Revenues
Revenues
35228000000 USD
us-gaap Revenues
Revenues
116233000000 USD
us-gaap Revenues
Revenues
108181000000 USD
CY2020Q1 us-gaap Revenues
Revenues
39157000000 USD
CY2019Q1 us-gaap Revenues
Revenues
35228000000 USD
us-gaap Revenues
Revenues
116233000000 USD
us-gaap Revenues
Revenues
108181000000 USD
CY2020Q1 cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
17000000 USD
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
37000000 USD
cah Project Costs On Investment And Other Spending
ProjectCostsOnInvestmentAndOtherSpending
36000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
562000000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
432000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4368000000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
1752000000 USD
CY2020Q1 us-gaap Assets
Assets
41148000000 USD
CY2019Q2 us-gaap Assets
Assets
40963000000 USD
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27000000 USD
CY2019Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
23000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
68000000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
64000000 USD
CY2020Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
5000000 USD
CY2019Q1 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
4000000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
12000000 USD
us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
13000000 USD
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6000000 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.78
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6000000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
64.02
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5000000 shares
CY2020Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
63.96

Files In Submission

Name View Source Status
0000721371-20-000043-index-headers.html Edgar Link pending
0000721371-20-000043-index.html Edgar Link pending
0000721371-20-000043.txt Edgar Link pending
0000721371-20-000043-xbrl.zip Edgar Link pending
a20q310q033120form10-q.htm Edgar Link pending
a20q310q033120form10-q_htm.xml Edgar Link completed
a20q310q33120exhibit311.htm Edgar Link pending
a20q310q33120exhibit312.htm Edgar Link pending
a20q310q33120exhibit321.htm Edgar Link pending
a20q310q33120exhibit991.htm Edgar Link pending
cah-20200331.xsd Edgar Link pending
cah-20200331_cal.xml Edgar Link unprocessable
cah-20200331_def.xml Edgar Link unprocessable
cah-20200331_lab.xml Edgar Link unprocessable
cah-20200331_pre.xml Edgar Link unprocessable
chart-63966054a2b856539df.jpg Edgar Link pending
chart-84be621792a45ea38bb.jpg Edgar Link pending
chart-90453b3d6ed050ecbdc.jpg Edgar Link pending
chart-b4b418d5d2515afb95c.jpg Edgar Link pending
chart-c5eb687c6be4546d867.jpg Edgar Link pending
chart-d47fafa037625ec1989.jpg Edgar Link pending
chart-f71680c275d85d55b02.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending